Risk Of Developing Liver Cancer After HCV Treatment

▼
Wednesday, December 28, 2011

Optimization of Comorbidity Therapy to Achieve Sustained Viral Response in HCV Patients

›
Optimization of Comorbidity Therapy to Achieve Sustained Viral Response in HCV Patients Claudio Ucciferri1,2, Jacopo Vecchiet2, Eligio Pizzi...

Recent Trends of Japanese Hepatocellular Carcinoma due to HCV

›
Recent Trends of Japanese Hepatocellular Carcinoma due to HCV in Aging Society ; Hiraoka A, Hidaka S, Shimizu Y, Utsunomiya H, Imai Y, Tats...

Tailor-Made Therapy for Viral Hepatitis

›
Paper Tailor-Made Therapy for Viral Hepatitis: Recent Advances Masatoshi Kudo Department of Gastroenterology and Hepatology, Kinki Univer...

Hospital sued for improper sterilization of equipment; Fear of disease claimed

›
Hospital sued for improper sterilization of equipment; Fear of disease claimed 12/27/2011 7:59 AM By Kyle Barnett A New Orleans woman is sui...

Tattoos and Piercings: A Review for the Emergency Physician

›
Complications of Tattoos Tattoo complication rates show a prevalence of approximately 2% to 3%. Table 3 summarizes the complications ass...

Natural Variation in Drug Susceptibility to HCV Polymerase Inhibitors in Treatment-naïve HCV Patient Isolates

›
Source Medscape From Journal of Viral Hepatitis Natural Variation in Drug Susceptibility to HCV Polymerase Inhibitors in Treatment-naïve HCV...
Tuesday, December 27, 2011

Management of Hepatitis C Infection

›
From CCO Hepatology - Management of Hepatitis C Infection Authors: Jordan J. Feld, MD, MPH, Hemant Shah, MD, FRCPC Released: 12/13/11 ...
Monday, December 26, 2011

Hepatitis C News Ticker: Following response-guided therapy guidelines with boceprevir and telaprevir

›
"Reading the Paper" Lynne Crumpacker Hepatitis Journal Options – Volume 5, Issue 1 Now Available! CCO Hepatology inPrac...